IRIS
CHIODERA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.610
EU - Europa 4.901
AS - Asia 3.314
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 17
SA - Sud America 10
OC - Oceania 9
Totale 14.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.418
CN - Cina 1.936
FI - Finlandia 1.170
IE - Irlanda 1.120
SE - Svezia 894
SG - Singapore 839
DE - Germania 692
UA - Ucraina 560
TR - Turchia 453
IT - Italia 246
CA - Canada 192
IN - India 60
GB - Regno Unito 57
FR - Francia 56
BE - Belgio 46
NL - Olanda 23
IR - Iran 21
EU - Europa 18
CI - Costa d'Avorio 16
LT - Lituania 8
AT - Austria 6
HU - Ungheria 6
AU - Australia 5
BR - Brasile 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 4
PE - Perù 3
CZ - Repubblica Ceca 2
ES - Italia 2
JP - Giappone 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
HR - Croazia 1
MC - Monaco 1
MD - Moldavia 1
RO - Romania 1
TH - Thailandia 1
VE - Venezuela 1
Totale 14.879
Salva come PNG Salva come JPEG
Città #
Chandler 1.284
Jacksonville 1.156
Dublin 1.119
Singapore 673
Ashburn 554
Beijing 490
Dearborn 440
Izmir 439
Nanjing 337
San Mateo 254
Boardman 250
Princeton 234
Toronto 170
Shanghai 165
Ann Arbor 138
Des Moines 132
Nanchang 126
Shenyang 117
Düsseldorf 116
Wilmington 108
Kunming 103
Helsinki 82
Woodbridge 76
Hebei 69
Jinan 63
Hefei 55
Santa Clara 51
Leawood 48
Grafing 47
Brussels 46
Tianjin 40
Parma 38
Guangzhou 37
Jiaxing 37
Changsha 34
Seattle 31
Hangzhou 24
Pune 22
Augusta 21
Monmouth Junction 21
Rome 20
Bremen 17
Abidjan 16
Fremont 16
Fuzhou 16
New York 16
Zhengzhou 16
Ardabil 15
Taizhou 14
Borås 13
Kocaeli 13
London 12
Norwalk 12
Dallas 10
Haikou 10
Ottawa 10
Taiyuan 10
Chengdu 9
Los Angeles 9
Mestre 9
Ningbo 9
Rockville 9
Wenzhou 9
Miami 8
Munich 8
Huizen 7
Marseille 7
Phoenix 7
Wuhan 7
Lanzhou 6
Mumbai 6
Vienna 6
Baotou 5
Chongqing 5
Luxembourg 5
Milan 5
Sabz 5
Xian 5
Auburn Hills 4
Changchun 4
Mainz 4
Cagliari 3
Geislingen an der Steige 3
Lima 3
Redmond 3
Rio Saliceto 3
Shaoxing 3
Southend 3
Andover 2
Bangalore 2
Belo Horizonte 2
Bratislava 2
Chicago 2
Cutrofiano 2
Falls Church 2
Fiumalbo 2
Forlì 2
Frankfurt am Main 2
Hamilton 2
Las Pinas 2
Totale 9.686
Salva come PNG Salva come JPEG
Nome #
Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man. 300
Gonadotropine, prolattina e tireotropina nella S. di Klinefelter. 114
Livelli di prolattina, deidroepiandrosterone solfato, cortisolo, testosterone e 17-beta-estradiolo nell'alcolismo cronico. 103
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 99
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 99
Protein Kinase Cε Regulates Proliferation and Cell Sensitivity to TGF-1β of CD4+ T Lymphocytes: Implications for Hashimoto Thyroiditis 99
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 87
Studio parallelo di gonadotropine e prolattina in pazienti amenorroiche. 84
Glucagon response to insulin-induced hypoglycemia in obese men. 83
Blunted GH response from cigarette smoking in four week abstinent alcoholics. 83
Oxytocin reduces angiotensin II-induced ACTH release in men. 82
Sugli effetti di un trattamento policorticoide su gonadotropine, PRL e TSH (valori basali e risposta ipofisaria). 82
Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia. 81
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 80
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 79
Comportamento del settore gonadotropinico nella patologia espansiva diencefalo-ipofisaria prima e dopo trattamento neurochirurgico. 78
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 78
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 78
Oxytocin does not modify the PRL response to metoclopramide in normal women. 78
Ridotta responsività di ACTH/Cortisolo al naloxone nel Morbo di Parkinson. 78
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 77
Considerazioni sul comportamento della prolattina nelle displasie prostatiche. 77
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 77
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 77
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 76
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 76
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 76
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 76
Inhibition of growth hormone secretion in mild primary hyperparathyroidism 75
I fattori regolatori della secrezione di vasopressina. 75
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 75
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 75
TSH and PRL responses to metoclopramide and TRH in normal elderly men. 75
Gonadotropins, prolactin and thyrotropin (basal value and pituitary responses) in infertile male patients. 74
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 74
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 74
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 74
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 74
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 73
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 73
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 73
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 73
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 72
Reduction of nomifensine-induced growth hormone release in elderly men. 72
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 72
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 72
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 71
Age-related changed in growth hormone (GH) secretion in normally cycling women. 71
Gn-RH test for hypogonadic men. 71
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 71
Alteration in dopaminergic function in abstinent alcoholics. 71
Effect of metoclopramide on serum GH levels in normal women. 71
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 71
Oxytocin Response to challenging stimuli in elderly men. 71
Arginine-vasopressin (AVP) responses to osmotic, pressure-volumetric and hypoglycemic stimuli in women with polycistic ovaries (PCO) 71
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 71
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 70
Risposta di TSH e PRL al TRH nella patologia nodulare tiroidea 70
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 70
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 69
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 69
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 69
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 68
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 68
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 68
Effect of cimetidine on PRL secretion in elderly subjects. 68
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 68
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 68
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 68
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 67
Thyrotropin-releasing hormone does not inhibit lysine vasopressin-induced growth hormone secretion in normal men. 67
Prolattina ed osmoregolazione del liquido amniotico. 67
Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in men. 67
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 67
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 67
Somatostatin does not modulate arginine vasopressin and oxytocin responses to angiotensin II 66
Effect of naloxone on neurophysin secretion in normal women. 66
Opioid control of pituitary function in parkinsonian patients before and after dopaminergic therapy 66
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 66
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 66
Different effects of Delta-sleep-inducing peptide on arginine-vasopressin and ACTH secretion in normal men. 66
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 66
Patologia espansiva ipotalamo-ipofisaria: studio parallelo di TSH e PRL. 66
Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men 65
LH, FSH, TSH and PRL (basal values and pituitary responses) in oligo- and azospermic patients. 65
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 65
Effect of aging on arginine vasopressin response to physiostigmine and angiotensin II in normal men. 65
Livelli ematici di testosterone in corso di iperprolattinemia funzionale ed organica. 65
Effect of nitric oxide on basal and TRH- or metoclopramide-stimulated prolactin release in normal men 65
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 65
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 65
Oxytocin response to insulin-induced hypoglycaemia in obese subjects before and after weight loss. 65
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 65
Antiserotonergic and antihistaminergic agents do not antagonize naloxone-induced cortisol secretion in normal men. 65
Effect of substance P on basal and TRH-stimulated TSH release in humans 64
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 64
Inhibitory effect of dexamethasone on the oxytocin response to insulin-induced hypoglycemia in normal men. 64
Crenoidrokinesiterapia e supplementazione di vit. D3: un efficace binomio per ridurre il rischio di caduta in donne osteoporotiche con ipovitaminosi D3. 64
Dopaminergic and opioid receptor antagonist do not modify the secretory response of growth hormone to lysine-vasopressin in normal subjects. 64
Inhibitory effect of dexamethasone on arginine-vasopressin release induced by physical exercise in man 64
Totale 7.514
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.815 0 0 0 0 292 327 425 48 262 192 42 227
2020/20211.432 2 244 21 3 227 1 39 7 389 23 456 20
2021/20221.127 7 28 4 19 23 56 168 208 53 81 63 417
2022/20234.136 460 403 299 318 310 502 19 285 1.408 17 91 24
2023/20241.405 88 170 23 42 106 234 43 365 33 40 119 142
2024/20251.218 86 272 367 230 263 0 0 0 0 0 0 0
Totale 14.906